Surgical valve technologies

Surgical valve technologies

Abstract Background Remimazolam is a short-acting benzodiazepine with small circulatory depression. We used remimazolam for general anesthesia management in two

Read More

Surgical valve technologies

Abstract Background Clinicians continue to expand the availability of transcatheter aortic valve replacement (TAVR) for patients who historically would have

Read More

Surgical valve technologies

Abstract Purpose of review To synthesize and critically assess recent clinical and research advancements in pediatric bicuspid aortic valve (BAV)

Read More

Surgical valve technologies

Abstract Background Aortic stenosis is the most common valvulopathy in Western countries. The treatment of choice had been surgery aortic

Read More

Surgical valve technologies

Abstract Objective A substantial proportion of patients with rheumatic heart disease (RHD) have tricuspid regurgitation (TR). This study aimed to

Read More

Surgical valve technologies

Abstract Background The prevalence of calcific aortic stenosis and amyloid transthyretin cardiomyopathy (ATTR‐CM) increase with age, and they often coexist.

Read More

Surgical valve technologies

Abstract Background When feasible, guidelines recommend mitral valve repair (MVr) over mitral valve replacement (MVR) to treat primary mitral regurgitation

Read More

Surgical valve technologies

Abstract Objective The optimal medical therapy after surgical aortic valve replacement (SAVR) for aortic stenosis remains unknown. Renin–angiotensin system (RAS)

Read More

Surgical valve technologies

Read More

Surgical valve technologies

Abstract Background This study assessed risk factors for mitral regurgitation (MR) recurrence or functional mitral stenosis during long‐term follow‐up in

Read More

1 3 4 5 6 7 11